Do COVID-19 Infectious Disease Models Incorporate the Social Determinants of Health? A Systematic Review
John-Baptiste A, Moulin M, Li Z, Hamilton D, Crichlow G, Klein D, Alemu F, Ghattas L, McDonald K, Asaria M, Sharpe C, Pandya E, Moqueet N, Champredon D, Moghadas S, Cooper L, Pinto A, Stranges S, Haworth-Brockman M, Galvani A, Ali S. Do COVID-19 Infectious Disease Models Incorporate the Social Determinants of Health? A Systematic Review. Public Health Reviews 2024, 45: 1607057. PMID: 39450316, PMCID: PMC11499127, DOI: 10.3389/phrs.2024.1607057.Peer-Reviewed Original ResearchSocial determinants of healthDeterminants of healthSocial determinantsAppraised study qualityWeb of ScienceStudy qualityTargeted interventionsStudy characteristicsPractice guidelinesCochrane LibraryRemote/rural locationsCOVID-19HealthUnited StatesMultiple countriesDifferential impactAgeRace/ethnicityMEDLINEEmbaseInterventionCochraneMathematical modeling studiesPandemicDisease modelsEarly Release - Public Health Impact of Paxlovid as Treatment for COVID-19, United States - Volume 30, Number 2—February 2024 - Emerging Infectious Diseases journal - CDC
Bai Y, Du Z, Wang L, Lau E, Fung I, Holme P, Cowling B, Galvani A, Krug R, Meyers L. Early Release - Public Health Impact of Paxlovid as Treatment for COVID-19, United States - Volume 30, Number 2—February 2024 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2024, 30: 262-269. PMID: 38181800, PMCID: PMC10826746, DOI: 10.3201/eid3002.230835.Peer-Reviewed Original Research